Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v14-FR | Version v13-EN | |
---|---|---|
Language | French | English |
Date Updated | 2017-08-07 | 2017-08-07 |
Drug Identification Number | 02390981 | 02390981 |
Brand name | TOPOTECAN INJECTION | TOPOTECAN INJECTION |
Common or Proper name | Topotecan HCl | Topotecan HCl |
Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
Ingredients | TOPOTECAN | TOPOTECAN |
Strength(s) | 1MG | 1MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 5x4mL fiole/vial | 5x4mL fiole/vial |
ATC code | L01XX | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | ||
Actual start date | 2016-12-13 | 2016-12-13 |
Estimated end date | 2017-07-28 | 2017-07-28 |
Actual end date | 2017-07-28 | 2017-07-28 |
Shortage status | Resolved | Resolved |
Tier 3 Status | No | No |
Company comments | Stock available at some wholesalers/Inventaire disponible chez certains grossistes | Stock available at some wholesalers/Inventaire disponible chez certains grossistes |
Health Canada comments |